Your browser doesn't support javascript.
loading
Risk reduction and screening of cancer in hereditary breast-ovarian cancer syndromes: ESMO Clinical Practice Guideline.
Sessa, C; Balmaña, J; Bober, S L; Cardoso, M J; Colombo, N; Curigliano, G; Domchek, S M; Evans, D G; Fischerova, D; Harbeck, N; Kuhl, C; Lemley, B; Levy-Lahad, E; Lambertini, M; Ledermann, J A; Loibl, S; Phillips, K-A; Paluch-Shimon, S.
Affiliation
  • Sessa C; Medical Oncology, Oncology Institute of Southern Switzerland, EOC, Bellinzona, Switzerland.
  • Balmaña J; Medical Oncology Hospital Vall d'Hebron and Hereditary Cancer Genetics Group, Vall d'Hebron Institut of Oncology, Barcelona, Spain.
  • Bober SL; Department of Psychosocial Oncology and Palliative Care, Dana-Farber Cancer Institute/Harvard Medical School, Boston, USA.
  • Cardoso MJ; Champalimaud Foundation, Breast Unit and Faculdade de Medicina, Lisbon, Portugal.
  • Colombo N; Department of Gynecologic Oncology, Istituto Europeo di Oncologia e IRCCS, Milan, Italy; Department of Medicine and Surgery, University of Milano-Bicocca, Milan, Italy.
  • Curigliano G; Early Drug Development for Innovative Therapies Division, Istituto Europeo di Oncologia, IRCCS, Milan, Italy; Department of Oncology and Hemato-Oncology, University of Milano, Milan, Italy.
  • Domchek SM; Basser Center for BRCA, Abramson Cancer Center, University of Pennsylvania, Philadelphia, USA.
  • Evans DG; Manchester Centre for Genomic Medicine, Division of Evolution Infection and Genomic Sciences, University of Manchester, MAHSC, Manchester, UK; Manchester Centre for Genomic Medicine, MAHSC, St Mary's Hospital, Manchester University Hospitals NHS Foundation Trust, Manchester, UK.
  • Fischerova D; Gynecologic Oncology Center, Department of Obstetrics and Gynecology, First Faculty of Medicine, Charles University and General University Hospital in Prague, Prague, Czech Republic.
  • Harbeck N; Breast Center, Department of Obstetrics & Gynecology and Comprehensive Cancer Center Munich, LMU University Hospital, Munich, Germany.
  • Kuhl C; Department of Diagnostic and Interventional Radiology, University Hospital Aachen, University Hospital Aachen (UKA), RWTH Aachen, Germany.
  • Lemley B; KIU - Patient Organisation for Women with Gynaecological Cancer, Copenhagen, Denmark; Clinical Trials Project, ESGO ENGAGe, Prague, Czech Republic.
  • Levy-Lahad E; Medical Genetics Institute, Shaare Zedek Medical Center, Faculty of Medicine, The Hebrew University of Jerusalem, Jerusalem, Israel.
  • Lambertini M; Department of Internal Medicine and Medical Specialties (DiMI), School of Medicine, University of Genova, Genoa, Italy; Department of Medical Oncology, U.O. Clinica di Oncologia Medica, IRCCS Ospedale Policlinico San Martino, Genoa, Italy.
  • Ledermann JA; Department of Oncology, UCL Cancer Institute, University College London and UCL Hospitals, London, UK.
  • Loibl S; GBG Forschungs GmbH, Neu-Isenburg, Germany.
  • Phillips KA; Department of Medical Oncology, Peter MacCallum Cancer Centre and The Sir Peter MacCallum Department of Oncology, The University of Melbourne, Melbourne, Australia.
  • Paluch-Shimon S; Sharett Institute of Oncology Department, Hadassah University Hospital & Faculty of Medicine Hebrew University, Jerusalem, Israel.
Ann Oncol ; 34(1): 33-47, 2023 01.
Article in En | MEDLINE | ID: mdl-36307055
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplastic Syndromes, Hereditary / Breast Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies / Screening_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Ovarian Neoplasms / Neoplastic Syndromes, Hereditary / Breast Neoplasms Type of study: Diagnostic_studies / Etiology_studies / Guideline / Risk_factors_studies / Screening_studies Limits: Female / Humans Language: En Journal: Ann Oncol Journal subject: NEOPLASIAS Year: 2023 Document type: Article Affiliation country: Switzerland Country of publication: United kingdom